Med-Chemist : "Quintessential Medicinal Chemistry"
Saturday, May 21, 2011
FDA approves Sutent for patients with progressive neuroendocrine cancerous tumors in pancreas
In continuation of my update on
Sutent
FDA approves Sutent for patients with progressive neuroendocrine cancerous tumors in pancreas
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment